Recce Pharmaceuticals Completes Stage 1 Data Analysis of : c

Patients with bacterial infections successfully treated with RECCE® 327 (R327)Deadly bacterial pathogens treated with R327 include those identified by the...

Related Keywords

Sydney , New South Wales , Australia , United States , Australian , Andrew Geddes , Jordyn Temperato , James Graham , Guillame Van Renterghem , Therapeutic Goods Administration , Lifesci Communications , World Health Organization Priority Pathogen , Recce Pharmaceuticals , World Health Organization , Recce Pharmaceuticals Ltd , Pharmaceuticals Ltd , West Australian Government , Chief Executive Officer , Priority Pathogen , Special Access Scheme , Fiona Stanley Hospital Burns Unit , New Class , Synthetic Anti Infectives , Infectious Disease Product , Generating Antibiotic Initiatives Now , Fast Track Designation , Pew Charitable Trusts Global New Antibiotics , Development Pipeline , Investor Relations , Australian Stock Exchange Rce Ax ,